The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator

• Auteurs principaux: Varsha D. Shiragannavar (Auteur), Nirmala G. Sannappa Gowda (Auteur), Lakshana D. Puttahanumantharayappa (Auteur), Shreyas H. Karunakara (Auteur), Smitha Bhat (Auteur), Shashanka K. Prasad (Auteur), Divya P. Kumar (Auteur), Prasanna K. Santhekadur (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Introduction: Non-alcoholic fatty liver disease (NAFLD) incidence has been rapidly increasing, and it has emerged as one of the major diseases of the modern world. NAFLD constitutes a simple fatty liver to chronic non-alcoholic steatohepatitis (NASH), which often leads to liver fibrosis or cirrhosis...